Xiaobai Li

1.2k citations
33 papers · 591 indexed · h-index 14
Topics
Renal cell carcinoma treatment (6 papers)Childhood Cancer Survivors' Quality of Life (3 papers)Parathyroid Disorders and Treatments (3 papers)

In The Last Decade

Xiaobai Li

33 papers receiving 584 citations

Peers

Xiaobai Li
Comparison fields: 5 of 89
  • Oncology 142
  • Surgery 126
  • Pathology and Forensic Medicine 109
  • Molecular Biology 100
  • Pulmonary and Respiratory Medicine 88
Replace Silje Watterdal Syversen with:
Silje Watterdal Syversen Norway
Vern C. Juel United States
Tolga Köroğlu Türkiye
Sara Reis Teixeira Brazil
Thomas Reiter Austria
Junzo Nojima Japan
Raffi Topakian Austria
Ben Illigens United States
P. Willeke Germany
Frank Donnerstag Germany
Xiaobai Li relative to Silje Watterdal Syversen Norway Silje Watterdal Syversen's profile →
Citations per field
00.5×2.8×
Silje Watterdal Syversen · 1×
Citations per year

Countries citing papers authored by Xiaobai Li

Since Specialization
Citations

This map shows the geographic impact of Xiaobai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobai Li more than expected).

Fields of papers citing papers by Xiaobai Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobai Li. The network helps show where Xiaobai Li may publish in the future.

Co-authorship network of co-authors of Xiaobai Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobai Li. A scholar is included among the top collaborators of Xiaobai Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobai Li. Xiaobai Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 6
5 4
6 11
7 3
8 14
9 3
10 6
11 55
12 17
13 1
14 14
15 91
16 20
17 120
18 6
19 5
20 18

About Xiaobai Li

Xiaobai Li is a scholar working on Nephrology, General Dentistry and Applied Microbiology and Biotechnology, having authored 33 papers that have together received 591 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Parathyroid Disorders and Treatments (3 papers). The work is most often cited by research in Nephrology (47 citations), Genetics (70 citations) and Pathology and Forensic Medicine (109 citations). Xiaobai Li has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Tanios Bekaii‐Saab, Mark M. Zalupski, Bassel F. El‐Rayes, Todd M. Bauer, Clelia Pellicano, Mary Ehrmantraut, Antonio Gallo, Philip A. Philip, Henry F. McFarland and Vasiliki N. Ikonomidou. Their work appears in journals such as PLoS ONE, PEDIATRICS and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026